SCHEMBL9066588

SCHEMBL9066588

CS(=O)(=O)N1CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL477197 0.84 KDM4E (0.52)
SCHEMBL5013 0.84 KDM4E (0.52)
Piperazine SCHEMBL28080505 0.82 KDM4E (0.50)
Potassium SCHEMBL30601760 0.82 KDM4E (0.50)
Hydrochloric Acid SCHEMBL311054 0.82 KDM4E (0.50)
SCHEMBL8742086 0.82 KDM4E (0.50)
SCHEMBL22073213 0.79
SCHEMBL16733020 0.77
SCHEMBL92545 0.76 KDM4E (0.56)
Methylene Chloride SCHEMBL16447276 0.76 KDM4E (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3091012-A1 CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF Centrexion Therapeutics Corporation (US) 2016-11-09 EP disclosed
EP-2816040-A1 Process for the production of CCR2 receptor antagonists and intermediates thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-12-24 EP disclosed
EP-2813503-A1 A process for the production of new CCR2 receptor antagonists and intermediates thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-12-17 EP disclosed
EP-0729484-A1 CURE INHIBITED EPOXY RESIN COMPOSITIONS AND LAMINATES PREPARED FROM THE COMPOSITIONS THE DOW CHEMICAL COMPANY (US) 1996-09-04 EP disclosed
WO-1995012627-A1 CURE INHIBITED EPOXY RESIN COMPOSITIONS AND LAMINATES PREPARED FROM THE COMPOSITIONS THE DOW CHEMICAL COMPANY (US) 1995-05-11 WO disclosed